Passer au contenu principal

oncostatin M receptor

La OSMR gene provides instructions for making a protein called oncostatin M receptor beta subunit (OSMRβ). This protein is one piece (subunit) of both the oncostatin M (OSM) receptor type II and the interleukin-31 (IL-31) receptor. These receptors are embedded in the cell membrane of many types of cells throughout the body. Each attaches to a particular protein, fitting together like a lock and its key. This attachment triggers a series of chemical signals inside the cell that directs certain cell functions.

Sélections vidéo pour Gènes
Bibliothèque vidéo

Normal function

La OSMR gene provides instructions for making a protein called oncostatin M receptor beta subunit (OSMRβ). This protein is one piece (subunit) of both the oncostatin M (OSM) receptor type II and the interleukin-31 (IL-31) receptor. These receptors are embedded in the cell membrane of many types of cells throughout the body. Each attaches to a particular protein, fitting together like a lock and its key. This attachment triggers a series of chemical signals inside the cell that directs certain cell functions.

OSM receptor type II interacts with a protein called oncostatin M (OSM). Signaling triggered by OSM was first recognized to block the growth of cancerous cells and appears to play a role in many other body processes, including the development of blood cells, the maturation of cells to become certain cell types, and an immune system response called inflammation. The signaling may also block the self-destruction (apoptosis) of cells.

The IL-31 receptor interacts with a protein called IL-31. Signaling triggered by IL-31 is involved in inflammation and stimulating itching (pruritus), although its role is not completely understood.

Conditions referring to this gene or chromosome

Other names

IL-31 receptor subunit beta

IL-31R subunit beta

IL-31R-beta

IL-31RB

interleukin-31 receptor subunit beta

oncostatin-M specific receptor beta subunit

OSMRB

PLCA1

Related patient information and medicines

néphropathie à IgA

Patient information leaflet

néphropathie à IgA

néphropathie à IgA is a condition in which a protein causes damage to the kidneys. The medicines used for blood pressure control with IgA nephropathy are angiotensin-converting enzyme (ACE) inhibitors ACE inhibitors or angiotensin receptor blockers (ARBs) - for example, losartan Losartan - an angiotensin receptor blocker. Even if you don't have high.

Pontage aortocoronarien

Patient information leaflet

Pontage aortocoronarien

C oronary artery bypass grafting (CABG) is a type of heart surgery to treat coronary artery disease. The standard surgery requires open heart surgery and stopping of the heart temporarily. Coronary artery bypass grafting, called CABG for short (pronounced 'cabbage'), is a heart operation. It is also called coronary artery bypass surgery. A CABG is.

Cardiomyopathie dilatée

Patient information leaflet

Cardiomyopathie dilatée

Cardiomyopathie dilatée is a condition where the heart muscle becomes stretched and thin. The heart becomes enlarged (dilates) and pumps blood less well. Symptoms vary according to severity and the treatment depends on the type of symptoms and whether any complications develop. Some forms of dilated cardiomyopathy run in families. A normal heart.

Hypercholestérolémie familiale

Patient information leaflet

Hypercholestérolémie familiale

Hypercholestérolémie familiale is inherited high cholesterol. The usual medicine to start with is a statin Statins and other lipid-lowering medicines. ...mmon statine used is called atorvastatinDr Krishna Vakharia , 13th September 2024 The National Institute for Health and Care Excellence (NICE) is recommending evinacumab alongside diet and other.

Diabète et maladie

Patient information leaflet

Diabète et maladie

It is very important to know how to cope with illness if you have diabète or know or care for somebody with diabetes. Further information on managing diabetes pendant a period of illness est available sur le Diabète UK website (see Further Reading below for the link). On angiotensin-converting enzyme (ACE) inhibitors ACE inhibitors , angiotensin.

Myasthénie grave

Patient information leaflet

Myasthénie grave

Myasthenia gravis (MG) is a condition where muscles become easily tired and weak. It is due to a problem with how the nerves stimulate the muscles to tighten (contract). The muscles around the eyes are commonly affected first. What causes myasthenia gravis. Myasthenia gravis is an autoimmune disease. This means that the immune system The immune.

Historique de l'article

Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
  • 18 Aug 2020 | Dernière version
  • 1 Oct 2016 | Publié à l'origine

Participez à la conversation

Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.

Avertissement : The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Pharmacie en ligne, traitements et services de santé

Accès simple à des traitements fiables et à des services de santé en ligne.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Inscrivez-vous à la newsletter Patient

Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.

Veuillez entrer une adresse e-mail valide

En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.